Phase 1-2a dose-ranging study of TLK199 tablets in myelodysplastic syndrome (MDS).

Trial Profile

Phase 1-2a dose-ranging study of TLK199 tablets in myelodysplastic syndrome (MDS).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 May 2012

At a glance

  • Drugs Ezatiostat (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Telik
  • Most Recent Events

    • 14 Jan 2008 Status change from recruiting to completed.
    • 06 Dec 2007 Results will be presented at "Myelodysplastic Syndromes: Clinical Studies, Including Transplantation".
    • 10 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top